Search - tctmd.com

Displaying 201 - 220 of 542

Sort: Relevancy | Date

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

Presentation TCT 2019

TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures

Presenter: Adam Greenbaum

September 27, 2019

Presentation TCT 2019

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

Presenter: Chiu Wong

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

News Opinion Off Script TCT 2019

Off Script: Want a Glimpse of Healthcare 3.0? Look Beyond Physician Burnout

Kwan S. Lee

September 27, 2019

Presentation TCT 2019

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Presenter: Raj Makkar

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Presentation TCT 2019

TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc.

Presenter: John Forrest

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

Case Presentation

Presenter: Steven Yakubov

September 26, 2019

Presentation TCT 2019

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Presenter: Davide Capodanno

September 26, 2019

Presentation TCT 2019

Remaining Data Gaps After the Low-Risk TAVR RCTs

Presenter: Michael Borger

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Presenter: Michael Reardon

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the PARTNER 3 Trial

Presenter: Martin Leon

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Presentation TCT 2019

Case Presentation: Low-Risk AS

Presenter: Amisha Patel

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

Advertisement

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Portico Noninferior to Commercial TAVR Valves in IDE Study

TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Off Script: Want a Glimpse of Healthcare 3.0? Look Beyond Physician Burnout

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

TCT 2019 Day Two: Transcatheter Valves, New and Old

TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc.

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Case Presentation

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Remaining Data Gaps After the Low-Risk TAVR RCTs

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Deep-Dive: NEW Insights From the PARTNER 3 Trial

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Case Presentation: Low-Risk AS

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content